Selarsdi 51759-0708-13

Generic: Ustekinumab-Aekn

Package NDC

51759-0708-13

Manufacturer: Teva Pharmaceuticals Usa, Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: March 12, 2025
Listing Expires: December 31, 2026
Application: BLA761343

Need to source Selarsdi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Ustekinumab-Aekn	130 mg/26mL

Drug Class

Interleukin-12 Antagonist [EPC]Interleukin-12 Antagonists [MoA]Interleukin-23 Antagonist [EPC]

Selected Package

51759-0708-13Selected

1 VIAL, GLASS in 1 CARTON (51759-708-13) / 26 mL in 1 VIAL, GLASS